company background image
AMBEEPHA logo

Ambee Pharmaceuticals DSE:AMBEEPHA Stock Report

Last Price

৳668.00

Market Cap

৳1.6b

7D

-1.5%

1Y

25.7%

Updated

10 Jun, 2024

Data

Company Financials

Ambee Pharmaceuticals PLC

DSE:AMBEEPHA Stock Report

Market Cap: ৳1.6b

AMBEEPHA Stock Overview

Engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh.

AMBEEPHA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health2/6
Dividends0/6

Ambee Pharmaceuticals PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ambee Pharmaceuticals
Historical stock prices
Current Share Price৳668.00
52 Week High৳1,302.30
52 Week Low৳511.00
Beta-0.32
1 Month Change-11.29%
3 Month Change-16.47%
1 Year Change25.71%
3 Year Change60.23%
5 Year Change0.36%
Change since IPO4,118.95%

Recent News & Updates

Recent updates

Shareholder Returns

AMBEEPHABD PharmaceuticalsBD Market
7D-1.5%-1.9%-1.6%
1Y25.7%-24.0%-26.0%

Return vs Industry: AMBEEPHA exceeded the BD Pharmaceuticals industry which returned -24% over the past year.

Return vs Market: AMBEEPHA exceeded the BD Market which returned -26% over the past year.

Price Volatility

Is AMBEEPHA's price volatile compared to industry and market?
AMBEEPHA volatility
AMBEEPHA Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement6.7%
Market Average Movement5.3%
10% most volatile stocks in BD Market7.8%
10% least volatile stocks in BD Market3.2%

Stable Share Price: AMBEEPHA's share price has been volatile over the past 3 months.

Volatility Over Time: AMBEEPHA's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1976477Naureen Aziz Bhaiwww.ambeepharma.com

Ambee Pharmaceuticals PLC engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh. The company offers products in various therapeutic areas, including analgesic and antipyretic, anti-helmintic, antacid, anti-histamine, anti-protozoal and anti-fungal, antiasthmatic and antitussive, antibacterial, anticonvulstant, antiemetic, antihypertensive, antilipidemic agents, antiosteoarthritic, antispasmodic, antituberculer, antiulcerant, anxiolytic and hypnotic, cerebral vasodilator, corticosteroid drugs, diuretic agents, non-steroidal anti-inflammatory, steroidal anti-inflammatory drugs, haematinic, and vitamins and minerals. It also provides its products in form of tablets, capsules, liquids, tubes, and injections.

Ambee Pharmaceuticals PLC Fundamentals Summary

How do Ambee Pharmaceuticals's earnings and revenue compare to its market cap?
AMBEEPHA fundamental statistics
Market cap৳1.61b
Earnings (TTM)৳10.53m
Revenue (TTM)৳209.27m

152.3x

P/E Ratio

7.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMBEEPHA income statement (TTM)
Revenue৳209.27m
Cost of Revenue৳97.24m
Gross Profit৳112.04m
Other Expenses৳101.51m
Earnings৳10.53m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)4.39
Gross Margin53.54%
Net Profit Margin5.03%
Debt/Equity Ratio1,874.0%

How did AMBEEPHA perform over the long term?

See historical performance and comparison

Dividends

0.2%

Current Dividend Yield

34%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.